Business Description
Natural Health Trends Corp
NAICS : 453998
SIC : 5999
ISIN : US63888P4063
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 16.22 | |||||
Equity-to-Asset | 0.6 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -2.3 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.73 | |||||
Beneish M-Score | -2.17 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -11 | |||||
3-Year EPS without NRI Growth Rate | -10.6 | |||||
3-Year Book Growth Rate | -15.2 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.44 | |||||
9-Day RSI | 45.34 | |||||
14-Day RSI | 48.4 | |||||
6-1 Month Momentum % | 23.38 | |||||
12-1 Month Momentum % | 8.64 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.21 | |||||
Quick Ratio | 3 | |||||
Cash Ratio | 2.81 | |||||
Days Inventory | 152.84 | |||||
Days Payable | 28.34 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 11.94 | |||||
Dividend Payout Ratio | 16 | |||||
Forward Dividend Yield % | 11.94 | |||||
5-Year Yield-on-Cost % | 29.96 | |||||
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | 11.86 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 74.56 | |||||
Operating Margin % | -3.8 | |||||
Net Margin % | 1.29 | |||||
FCF Margin % | -9.84 | |||||
ROE % | 1.24 | |||||
ROA % | 0.75 | |||||
ROIC % | -7.02 | |||||
ROC (Joel Greenblatt) % | -41.82 | |||||
ROCE % | -3.03 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 134.2 | |||||
PE Ratio without NRI | 134.2 | |||||
Shiller PE Ratio | 3.92 | |||||
PS Ratio | 1.76 | |||||
PB Ratio | 1.86 | |||||
Price-to-Tangible-Book | 1.86 | |||||
EV-to-EBIT | -13.73 | |||||
EV-to-EBITDA | -15.23 | |||||
EV-to-Revenue | 0.52 | |||||
EV-to-FCF | -5.31 | |||||
Price-to-Projected-FCF | 1.37 | |||||
Price-to-Median-PS-Value | 1.47 | |||||
Price-to-Graham-Number | 3.32 | |||||
Price-to-Net-Current-Asset-Value | 2.1 | |||||
Price-to-Net-Cash | 2.69 | |||||
Earnings Yield (Greenblatt) % | -7.28 | |||||
FCF Yield % | -5.6 | |||||
Forward Rate of Return (Yacktman) % | 33.35 |